The federal government announced a new approach to regulating pharmaceutical ads. Consumers may not see a difference.

Vimeo is going private: The video platform, at one time a would-be competitor to YouTube, has agreed to be acquired by European tech company Bending Spoons, in an all-cash deal valued at approximately ...

NFL RedZone will no longer be “seven hours of commercial free football.” Going into the 2025 NFL season, and following the sale of RedZone to Disney/ESPN, the show is going through a slight transition ...

Interest rates range from around 5% to 14% for commercial real estate loans. But your specific rate will depend on lots of factors, such as the loan type, property and your creditworthiness. Many, or ...

Some Delaware Supreme Court justices signaled they may be skeptical of a bid by GSK Plc, Pfizer Inc. and other drugmakers to overturn a judge who allowed more than 80,000 lawsuits to proceed to trial ...

He is accusing GSK, formerly known as GlaxoSmithKline, of hiding the cancer risks of its once-popular heartburn drug, Zantac. Yost filed a motion on Monday requesting that the Ohio Public Employees ...

Judge Joshua Roberts entered an opinion Tuesday on his denial of a motion for his recusal from the Philadelphia Zantac mass tort. The plaintiffs in the Philadelphia Zantac mass tort had requested that ...

Nov 22 (Reuters) - A trial ended with a hung jury on Thursday in a California man's lawsuit alleging Boehringer Ingelheim's discontinued heartburn drug Zantac gave him bladder cancer. The jury in ...

This series, Space in Focus, explores key space trends, challenges, and policy issues that will confront the next administration as well as offers recommendations for how to navigate them. In the ...

How do you explain one Zantac manufacturer kiboshing a favorable trend of defense verdicts and decisions – with a massive $2.2 billion settlement? The answer appears to lie with the whistleblower suit ...

GSK GSK-1.61%decrease; red down pointing triangle agreed to pay more than $2 billion to settle almost all remaining liability cases in the U.S. over allegations its discontinued heartburn medicine ...

GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion. By Rebecca Robbins The British drug maker GSK said on Wednesday that it ...